Last 12 months
Inside the activity.
0 purchase rows · 26 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 7 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 24, 2021 Filed Nov 29, 2021 19:44 UTC |
HAMERSLAG STEVEN JDirector
|
SaleCommon Stock | 5,000 | $198.62 | $993,100.00 |
DisclosureSEC source: 0001056168-21-000008 · edgardoc.xml · nonDerivative · entry 1 HAMERSLAG STEVEN J · CIK 0001056168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,468 Read SEC document |
| November 23, 2021 Filed Nov 24, 2021 22:34 UTC |
CLEMONS V GORDONDirector · Chairman of the Board
|
SaleCommon Stock | 1,000 | $196.00 | $196,000.00 |
DisclosureSEC source: 0000946724-21-000090 · edgardoc.xml · nonDerivative · entry 2 CLEMONS V GORDON · CIK 0000946724 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Living Trust Disclosed balance after: 506,837 F1 · balance_after: The reported transaction was made by the Marie Eve Clemons Living Trust. The reporting person disclaims beneficial ownership to these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 purposes. Read SEC document |
| November 22, 2021 Filed Nov 24, 2021 22:34 UTC |
CLEMONS V GORDONDirector · Chairman of the Board
|
SaleCommon Stock | 1,000 | $198.15 | $198,150.70 |
DisclosureSEC source: 0000946724-21-000090 · edgardoc.xml · nonDerivative · entry 1 CLEMONS V GORDON · CIK 0000946724 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Living Trust Disclosed balance after: 507,837 F1 · balance_after: The reported transaction was made by the Marie Eve Clemons Living Trust. The reporting person disclaims beneficial ownership to these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 purposes. Read SEC document |
| November 19, 2021 Filed Nov 23, 2021 22:59 UTC |
Shishin MaximChief Information Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 500 | $0.00 Strike: $38.70 | $0.00 |
DisclosureSEC source: 0001703039-21-000012 · edgardoc.xml · derivative · entry 3 Shishin Maxim · CIK 0001703039 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 500 shares Expires 2022-02-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter. Read SEC document |
| November 19, 2021 Filed Nov 23, 2021 22:59 UTC |
Shishin MaximChief Information Officer
|
SaleCommon Stock | 500 | $195.60 | $97,800.00 |
DisclosureSEC source: 0001703039-21-000012 · edgardoc.xml · nonDerivative · entry 2 Shishin Maxim · CIK 0001703039 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600 Read SEC document |
| November 19, 2021 Filed Nov 23, 2021 22:59 UTC |
Shishin MaximChief Information Officer
|
Exercise / conversionCommon Stock | 500 | $38.70 | $19,350.00 |
DisclosureSEC source: 0001703039-21-000012 · edgardoc.xml · nonDerivative · entry 1 Shishin Maxim · CIK 0001703039 · Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 18, 2021 Filed Nov 18, 2021 23:24 UTC |
CLEMONS V GORDONDirector · Chairman of the Board
|
SaleCommon Stock | 1,000 | $193.50 | $193,495.50 |
DisclosureSEC source: 0000946724-21-000088 · edgardoc.xml · nonDerivative · entry 2 CLEMONS V GORDON · CIK 0000946724 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Living Trust Disclosed balance after: 508,837 F1 · balance_after: The reported transaction was made by the Marie Eve Clemons Living Trust. The reporting person disclaims beneficial ownership to these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 purposes. Read SEC document |
| November 16, 2021 Filed Nov 18, 2021 23:24 UTC |
CLEMONS V GORDONDirector · Chairman of the Board
|
SaleCommon Stock | 1,370 | $195.05 | $267,213.02 |
DisclosureSEC source: 0000946724-21-000088 · edgardoc.xml · nonDerivative · entry 1 CLEMONS V GORDON · CIK 0000946724 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Living Trust Disclosed balance after: 509,837 F1 · balance_after: The reported transaction was made by the Marie Eve Clemons Living Trust. The reporting person disclaims beneficial ownership to these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 purposes. Read SEC document |
| November 12, 2021 Filed Nov 16, 2021 23:15 UTC |
CLEMONS V GORDONDirector · Chairman of the Board
|
SaleCommon Stock | 1,000 | $193.67 | $193,665.10 |
DisclosureSEC source: 0000946724-21-000086 · edgardoc.xml · nonDerivative · entry 1 CLEMONS V GORDON · CIK 0000946724 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Living Trust Disclosed balance after: 511,207 F1 · balance_after: The reported transaction was made by the Marie Eve Clemons Living Trust. The reporting person disclaims beneficial ownership to these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 purposes. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 19:08 UTC |
O'Brien BrandonChief Financial Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 510 | $0.00 Strike: $59.32 | $0.00 |
DisclosureSEC source: 0001754499-21-000019 · edgardoc.xml · derivative · entry 15 O'Brien Brandon · CIK 0001754499 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,333 Underlying: Common Stock · 510 shares Expires 2023-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option will vest based on achievement of certain performance criteria relating to earnings growth. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 19:08 UTC |
O'Brien BrandonChief Financial Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 331 | $0.00 Strike: $59.32 | $0.00 |
DisclosureSEC source: 0001754499-21-000019 · edgardoc.xml · derivative · entry 14 O'Brien Brandon · CIK 0001754499 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,843 Underlying: Common Stock · 331 shares Expires 2023-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option will vest based on achievement of certain performance criteria relating to earnings growth. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 19:08 UTC |
O'Brien BrandonChief Financial Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 105 | $0.00 Strike: $57.35 | $0.00 |
DisclosureSEC source: 0001754499-21-000019 · edgardoc.xml · derivative · entry 13 O'Brien Brandon · CIK 0001754499 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187 Underlying: Common Stock · 105 shares Expires 2023-08-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 19:08 UTC |
O'Brien BrandonChief Financial Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 42 | $0.00 Strike: $49.40 | $0.00 |
DisclosureSEC source: 0001754499-21-000019 · edgardoc.xml · derivative · entry 12 O'Brien Brandon · CIK 0001754499 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50 Underlying: Common Stock · 42 shares Expires 2023-05-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 19:08 UTC |
O'Brien BrandonChief Financial Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 12 | $0.00 Strike: $48.35 | $0.00 |
DisclosureSEC source: 0001754499-21-000019 · edgardoc.xml · derivative · entry 11 O'Brien Brandon · CIK 0001754499 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12 shares Expires 2022-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 19:08 UTC |
O'Brien BrandonChief Financial Officer
|
SaleCommon Stock | 12 | $189.50 | $2,274.00 |
DisclosureSEC source: 0001754499-21-000019 · edgardoc.xml · nonDerivative · entry 10 O'Brien Brandon · CIK 0001754499 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,656 Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 19:08 UTC |
O'Brien BrandonChief Financial Officer
|
Exercise / conversionCommon Stock | 12 | $48.35 | $580.20 |
DisclosureSEC source: 0001754499-21-000019 · edgardoc.xml · nonDerivative · entry 9 O'Brien Brandon · CIK 0001754499 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,668 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 19:08 UTC |
O'Brien BrandonChief Financial Officer
|
SaleCommon Stock | 42 | $189.50 | $7,959.00 |
DisclosureSEC source: 0001754499-21-000019 · edgardoc.xml · nonDerivative · entry 8 O'Brien Brandon · CIK 0001754499 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,656 Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 19:08 UTC |
O'Brien BrandonChief Financial Officer
|
Exercise / conversionCommon Stock | 42 | $49.40 | $2,074.80 |
DisclosureSEC source: 0001754499-21-000019 · edgardoc.xml · nonDerivative · entry 7 O'Brien Brandon · CIK 0001754499 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,698 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 19:08 UTC |
O'Brien BrandonChief Financial Officer
|
SaleCommon Stock | 105 | $189.50 | $19,897.50 |
DisclosureSEC source: 0001754499-21-000019 · edgardoc.xml · nonDerivative · entry 6 O'Brien Brandon · CIK 0001754499 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,656 Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 19:08 UTC |
O'Brien BrandonChief Financial Officer
|
Exercise / conversionCommon Stock | 105 | $57.35 | $6,021.75 |
DisclosureSEC source: 0001754499-21-000019 · edgardoc.xml · nonDerivative · entry 5 O'Brien Brandon · CIK 0001754499 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,761 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 19:08 UTC |
O'Brien BrandonChief Financial Officer
|
SaleCommon Stock | 510 | $189.50 | $96,645.00 |
DisclosureSEC source: 0001754499-21-000019 · edgardoc.xml · nonDerivative · entry 4 O'Brien Brandon · CIK 0001754499 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,656 Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 19:08 UTC |
O'Brien BrandonChief Financial Officer
|
Exercise / conversionCommon Stock | 510 | $59.32 | $30,253.20 |
DisclosureSEC source: 0001754499-21-000019 · edgardoc.xml · nonDerivative · entry 3 O'Brien Brandon · CIK 0001754499 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,166 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 19:08 UTC |
O'Brien BrandonChief Financial Officer
|
SaleCommon Stock | 331 | $189.50 | $62,724.50 |
DisclosureSEC source: 0001754499-21-000019 · edgardoc.xml · nonDerivative · entry 2 O'Brien Brandon · CIK 0001754499 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,656 Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 19:08 UTC |
O'Brien BrandonChief Financial Officer
|
Exercise / conversionCommon Stock | 331 | $59.32 | $19,634.92 |
DisclosureSEC source: 0001754499-21-000019 · edgardoc.xml · nonDerivative · entry 1 O'Brien Brandon · CIK 0001754499 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,987 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 18:21 UTC |
JESSUP R JUDDDirector
|
GiftCommon Stock | 2,705 | $0.00 | $0.00 |
DisclosureSEC source: 0001204612-21-000012 · edgardoc.xml · nonDerivative · entry 1 JESSUP R JUDD · CIK 0001204612 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,865 F1 · kind: Gift to adult child Read SEC document |
| November 04, 2021 Filed Nov 8, 2021 23:41 UTC |
CLEMONS V GORDONDirector · Chairman of the Board
|
SaleCommon Stock | 1,000 | $186.00 | $186,000.00 |
DisclosureSEC source: 0000946724-21-000084 · edgardoc.xml · nonDerivative · entry 1 CLEMONS V GORDON · CIK 0000946724 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Living Trust Disclosed balance after: 512,207 F1 · balance_after: The reported transaction was made by the Marie Eve Clemons Living Trust. The reporting person disclaims beneficial ownership to these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 purposes. Read SEC document |
| November 04, 2021 Filed Nov 8, 2021 22:49 UTC |
JESSUP R JUDDDirector
|
GiftCommon Stock | 8,115 | $0.00 | $0.00 |
DisclosureSEC source: 0001204612-21-000010 · edgardoc.xml · nonDerivative · entry 1 JESSUP R JUDD · CIK 0001204612 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,570 F1 · kind: Gift to three adult children Read SEC document |
| October 19, 2021 Filed Oct 21, 2021 22:00 UTC |
CLEMONS V GORDONDirector · Chairman of the Board
|
SaleCommon Stock | 1,000 | $175.49 | $175,488.70 |
DisclosureSEC source: 0000946724-21-000082 · edgardoc.xml · nonDerivative · entry 1 CLEMONS V GORDON · CIK 0000946724 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Living Trust Disclosed balance after: 513,207 F1 · balance_after: The reported transaction was made by the Marie Eve Clemons Living Trust. The reporting person disclaims beneficial ownership to these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 purposes. Read SEC document |
| October 18, 2021 Filed Oct 18, 2021 22:42 UTC |
CLEMONS V GORDONDirector · Chairman of the Board
|
SaleCommon Stock | 2,000 | $172.94 | $345,874.40 |
DisclosureSEC source: 0000946724-21-000080 · edgardoc.xml · nonDerivative · entry 3 CLEMONS V GORDON · CIK 0000946724 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Living Trust Disclosed balance after: 514,207 F1 · balance_after: The reported transaction was made by the Marie Eve Clemons Living Trust. The reporting person disclaims beneficial ownership to these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 purposes. Read SEC document |
| October 15, 2021 Filed Oct 18, 2021 22:42 UTC |
CLEMONS V GORDONDirector · Chairman of the Board
|
SaleCommon Stock | 2,000 | $174.18 | $348,366.60 |
DisclosureSEC source: 0000946724-21-000080 · edgardoc.xml · nonDerivative · entry 2 CLEMONS V GORDON · CIK 0000946724 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Living Trust Disclosed balance after: 516,207 F1 · balance_after: The reported transaction was made by the Marie Eve Clemons Living Trust. The reporting person disclaims beneficial ownership to these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 purposes. Read SEC document |
| October 14, 2021 Filed Oct 18, 2021 22:42 UTC |
CLEMONS V GORDONDirector · Chairman of the Board
|
SaleCommon Stock | 2,000 | $169.36 | $338,719.60 |
DisclosureSEC source: 0000946724-21-000080 · edgardoc.xml · nonDerivative · entry 1 CLEMONS V GORDON · CIK 0000946724 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Living Trust Disclosed balance after: 518,207 F1 · balance_after: The reported transaction was made by the Marie Eve Clemons Living Trust. The reporting person disclaims beneficial ownership to these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 purposes. Read SEC document |
| October 13, 2021 Filed Oct 13, 2021 21:40 UTC |
CLEMONS V GORDONDirector · Chairman of the Board
|
SaleCommon Stock | 2,000 | $168.62 | $337,245.00 |
DisclosureSEC source: 0000946724-21-000078 · edgardoc.xml · nonDerivative · entry 3 CLEMONS V GORDON · CIK 0000946724 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Living Trust Disclosed balance after: 520,207 F1 · balance_after: The reported transaction was made by the Marie Eve Clemons Living Trust. The reporting person disclaims beneficial ownership to these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 purposes. Read SEC document |
| October 12, 2021 Filed Oct 13, 2021 21:40 UTC |
CLEMONS V GORDONDirector · Chairman of the Board
|
SaleCommon Stock | 2,000 | $166.21 | $332,415.20 |
DisclosureSEC source: 0000946724-21-000078 · edgardoc.xml · nonDerivative · entry 2 CLEMONS V GORDON · CIK 0000946724 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Living Trust Disclosed balance after: 522,207 F1 · balance_after: The reported transaction was made by the Marie Eve Clemons Living Trust. The reporting person disclaims beneficial ownership to these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 purposes. Read SEC document |
| October 11, 2021 Filed Oct 13, 2021 21:40 UTC |
CLEMONS V GORDONDirector · Chairman of the Board
|
SaleCommon Stock | 2,000 | $169.26 | $338,529.80 |
DisclosureSEC source: 0000946724-21-000078 · edgardoc.xml · nonDerivative · entry 1 CLEMONS V GORDON · CIK 0000946724 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Living Trust Disclosed balance after: 524,207 F1 · balance_after: The reported transaction was made by the Marie Eve Clemons Living Trust. The reporting person disclaims beneficial ownership to these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 purposes. Read SEC document |
| October 08, 2021 Filed Oct 8, 2021 23:38 UTC |
CLEMONS V GORDONDirector · Chairman of the Board
|
SaleCommon Stock | 2,000 | $173.72 | $347,440.00 |
DisclosureSEC source: 0000946724-21-000076 · edgardoc.xml · nonDerivative · entry 3 CLEMONS V GORDON · CIK 0000946724 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Living Trust Disclosed balance after: 526,207 F1 · balance_after: The reported transaction was made by the Marie Eve Clemons Living Trust. The reporting person disclaims beneficial ownership to these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 purposes. Read SEC document |
| October 07, 2021 Filed Oct 8, 2021 23:38 UTC |
CLEMONS V GORDONDirector · Chairman of the Board
|
SaleCommon Stock | 2,000 | $175.36 | $350,726.00 |
DisclosureSEC source: 0000946724-21-000076 · edgardoc.xml · nonDerivative · entry 2 CLEMONS V GORDON · CIK 0000946724 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Living Trust Disclosed balance after: 528,207 F1 · balance_after: The reported transaction was made by the Marie Eve Clemons Living Trust. The reporting person disclaims beneficial ownership to these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 purposes. Read SEC document |
| October 06, 2021 Filed Oct 8, 2021 23:38 UTC |
CLEMONS V GORDONDirector · Chairman of the Board
|
SaleCommon Stock | 2,000 | $167.71 | $335,417.20 |
DisclosureSEC source: 0000946724-21-000076 · edgardoc.xml · nonDerivative · entry 1 CLEMONS V GORDON · CIK 0000946724 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Living Trust Disclosed balance after: 530,207 F1 · balance_after: The reported transaction was made by the Marie Eve Clemons Living Trust. The reporting person disclaims beneficial ownership to these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 purposes. Read SEC document |
| October 05, 2021 Filed Oct 5, 2021 21:43 UTC |
CLEMONS V GORDONDirector · Chairman of the Board
|
SaleCommon Stock | 2,000 | $189.42 | $378,843.80 |
DisclosureSEC source: 0000946724-21-000074 · edgardoc.xml · nonDerivative · entry 3 CLEMONS V GORDON · CIK 0000946724 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Living Trust Disclosed balance after: 532,207 F1 · balance_after: The reported transaction was made by the Marie Eve Clemons Living Trust. The reporting person disclaims beneficial ownership to these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 purposes. Read SEC document |
| October 04, 2021 Filed Oct 5, 2021 21:43 UTC |
CLEMONS V GORDONDirector · Chairman of the Board
|
SaleCommon Stock | 2,000 | $190.57 | $381,140.60 |
DisclosureSEC source: 0000946724-21-000074 · edgardoc.xml · nonDerivative · entry 2 CLEMONS V GORDON · CIK 0000946724 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Living Trust Disclosed balance after: 534,207 F1 · balance_after: The reported transaction was made by the Marie Eve Clemons Living Trust. The reporting person disclaims beneficial ownership to these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 purposes. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 21:43 UTC |
CLEMONS V GORDONDirector · Chairman of the Board
|
SaleCommon Stock | 2,000 | $184.55 | $369,093.80 |
DisclosureSEC source: 0000946724-21-000074 · edgardoc.xml · nonDerivative · entry 1 CLEMONS V GORDON · CIK 0000946724 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Living Trust Disclosed balance after: 536,207 F1 · balance_after: The reported transaction was made by the Marie Eve Clemons Living Trust. The reporting person disclaims beneficial ownership to these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 purposes. Read SEC document |
| September 30, 2021 Filed Oct 1, 2021 19:03 UTC |
Yoss JenniferVice President of Accounting
|
GrantCommon Stock | 14 | $176.91 | $2,476.73 |
DisclosureSEC source: 0001754632-21-000012 · edgardoc.xml · nonDerivative · entry 1 Yoss Jennifer · CIK 0001754632 · Vice President of Accounting 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245 F1 · balance_after: Shares acquired under the Issuer's Employee Stock Purchase Plan in a transaction exempt under SEC Rule 16b-3 (c) Read SEC document |
| September 30, 2021 Filed Oct 1, 2021 18:20 UTC |
Combs Michael GCEO & President
|
GrantCommon Stock | 18 | $176.91 | $3,184.36 |
DisclosureSEC source: 0001641248-21-000016 · edgardoc.xml · nonDerivative · entry 1 Combs Michael G · CIK 0001641248 · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,592 F1 · balance_after: Shares acquired under the Issuer's Employee Stock Purchase Plan in a transaction exempt under SEC Rule 16b-3 (c) Read SEC document |
| September 30, 2021 Filed Oct 1, 2021 18:43 UTC |
O'Brien BrandonChief Financial Officer
|
GrantCommon Stock | 7 | $176.91 | $1,238.36 |
DisclosureSEC source: 0001754499-21-000017 · edgardoc.xml · nonDerivative · entry 1 O'Brien Brandon · CIK 0001754499 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,656 F1 · balance_after: Shares acquired under the Issuer's Employee Stock Purchase Plan in a transaction exempt under SEC Rule 16b-3 (c) Read SEC document |
| September 30, 2021 Filed Oct 1, 2021 17:55 UTC |
BLAHA DIANEChief Marketing Officer
|
GrantCommon Stock | 66 | $176.91 | $11,675.99 |
DisclosureSEC source: 0001450607-21-000009 · edgardoc.xml · nonDerivative · entry 1 BLAHA DIANE · CIK 0001450607 · Chief Marketing Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,284 F1 · balance_after: Shares acquired under the Issuer's Employee Stock Purchase Plan in a transaction exempt under SEC Rule 16b-3 (c) Read SEC document |
| September 17, 2021 Filed Sep 21, 2021 19:14 UTC |
O'Brien BrandonChief Financial Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 1,000 | $177.39 Strike: $59.32 | $177,390.00 |
DisclosureSEC source: 0001754499-21-000015 · edgardoc.xml · derivative · entry 4 O'Brien Brandon · CIK 0001754499 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,174 Underlying: Common Stock · 1,000 shares Expires 2023-11-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option will vest based on achievement of certain performance criteria relating to earnings growth. Read SEC document |
| September 17, 2021 Filed Sep 21, 2021 19:14 UTC |
O'Brien BrandonChief Financial Officer
|
Tax withholdingCommon Stock | 230 | $177.39 | $40,799.70 |
DisclosureSEC source: 0001754499-21-000015 · edgardoc.xml · nonDerivative · entry 3 O'Brien Brandon · CIK 0001754499 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,649 F1 · kind: Shares delivered in payment of the option exercise price and/or tax liability incident to the option exercise. Read SEC document |
| September 17, 2021 Filed Sep 21, 2021 19:14 UTC |
O'Brien BrandonChief Financial Officer
|
Tax withholdingCommon Stock | 334 | $177.39 | $59,248.26 |
DisclosureSEC source: 0001754499-21-000015 · edgardoc.xml · nonDerivative · entry 2 O'Brien Brandon · CIK 0001754499 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,879 F1 · kind: Shares delivered in payment of the option exercise price and/or tax liability incident to the option exercise. Read SEC document |
| September 17, 2021 Filed Sep 21, 2021 19:14 UTC |
O'Brien BrandonChief Financial Officer
|
Exercise / conversionCommon Stock | 1,000 | $59.32 | $59,320.00 |
DisclosureSEC source: 0001754499-21-000015 · edgardoc.xml · nonDerivative · entry 1 O'Brien Brandon · CIK 0001754499 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,213 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 14, 2021 Filed Sep 16, 2021 22:06 UTC |
CLEMONS V GORDONDirector · Chairman of the Board
|
GiftCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000946724-21-000071 · edgardoc.xml · nonDerivative · entry 1 CLEMONS V GORDON · CIK 0000946724 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 900,000 F1 · kind: Gift to Foundation Read SEC document |
| September 08, 2021 Filed Sep 10, 2021 22:16 UTC |
CLEMONS V GORDONDirector · Chairman of the Board
|
SaleCommon Stock | 1,000 | $168.00 | $168,000.00 |
DisclosureSEC source: 0000946724-21-000069 · edgardoc.xml · nonDerivative · entry 1 CLEMONS V GORDON · CIK 0000946724 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Indirect · Spouse Living Trust Disclosed balance after: 538,207 F1 · balance_after: The reported transaction was made by the Marie Eve Clemons Living Trust. The reporting person disclaims beneficial ownership to these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for Section 16 purposes. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.